cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2002; 40:2165-2173
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bradham, W. S.
Right arrow Articles by Spinale, F. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bradham, W. S., Jr
Right arrow Articles by Spinale, F. G.

Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy

William S. Bradham, Jr, PhD*, Himali Gunasinghe, BS*, Jennifer R. Holder, BS*, Marlina Multani, MS*, Donna Killip, RN*, Marianne Anderson, RN{dagger}, Denise Meyer, RN{dagger}, William H. Spencer, III, MD, FACC*, Guillermo Torre-Amione, MD, FACC{dagger} and Francis G. Spinale, MD, PhD, FACC*,*

* Medical University of South Carolina, Charleston, South Carolina, USA
{dagger} Baylor College of Medicine, Houston, Texas, USA



View larger version (19K):

[in a new window]
 
Figure 1 (Top) The percent change in plasma total creatine kinase (CK) concentrations following alcohol injection into the septal perforator artery in patients with hypertrophic obstructive cardiomyopathy. Peak plasma CK levels occurred at 10 to 20 h post-injection. (Bottom) The percent change in CK MB1 isoform plasma concentrations following alcohol injection. A significant increase in CK-MB1 plasma levels was detected at 4 h and increased until 24 h following alcohol injection. *p < 0.05 vs. time 0; baseline values.

 


View larger version (20K):

[in a new window]
 
Figure 2 (Top) A small but significant change in matrix metalloproteinase (MMP)-2 plasma levels from baseline was observed at 4 h following alcohol injection. (Bottom) A significant increase in plasma MMP-9 levels occurred following alcohol injection and appeared to plateau for up to 50 h following injection. *p < 0.05 vs. time 0; baseline values.

 


View larger version (21K):

[in a new window]
 
Figure 3 (Top) Plasma matrix metalloproteinase (MMP)-8 levels increased in a time-dependent manner up to 24 h following alcohol injection of the septal perforator artery in patients with hypertrophic obstructive cardiomyopathy and plateaued for longer periods following alcohol injection. (Bottom) A fall in plasma MMP-13 levels was detected early following alcohol injection and was significant at 24 h. *p < 0.05 vs. time 0; baseline values.

 


View larger version (21K):

[in a new window]
 
Figure 4 (Top) Plasma tissue inhibitor of matrix metalloproteinase (TIMP)-1 levels did not change immediately following alcohol injection, but tended to rise at later time points; however, this did not reach statistical significance (p = 0.15). (Bottom) The ratio of plasma matrix metalloproteinase (MMP)-9/TIMP-1 levels was computed for each patient and plotted as a change from baseline values. A significant increase in this ratio occurred by 6 h following alcohol injection. *p > 0.15 vs. time 0; baseline values.

 


View larger version (18K):

[in a new window]
 
Figure 5 The area under the plasma concentration-time curve (AUC) was computed for each patient (n = 51) with respect to plasma creatine kinase MB1 fraction and matrix metalloproteinase (MMP)-9 levels. A significant linear relationship was observed between these two parameters.

 




 
  cardiology careers collections past issues search home